Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamilT P Miller, T M Grogan, W S Dalton, et al.
Blood|February 15, 1990
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group StudyB G Durie, D Stock-Novack, S E Salmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1983
Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopeciaJ C Dean, K S Griffith, T C Cetas, et al.
Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity|January 1, 1995
Idiotype specific peptides bind to the surface immunoglobulins of two murine B-cell lymphoma lines, inducing signal transductionK S Lam, Q Lou, Z G Zhao, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
One bead, one chemical compound: use of the selectide process for anticancer drug discoveryS E Salmon, K S Lam, S Felder, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
High dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myelomaJ P Fermand, S Chevret, C Hennequin, et al.
Anti-Cancer Drugs|February 1, 1991
In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugsD S Alberts, R T Dorr, T P Wunz, et al.
Blood|July 1, 1991
Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizerS E Salmon, W S Dalton, T M Grogan, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatantsE M Hersh, P Scuderi, W J Grimes, et al.
Cancer Treatment Reports|June 1, 1982
Activity of isotretinoin against squamous cell cancers and preneoplastic lesionsF L Meyskens, E Gilmartin, D S Alberts, et al.
Pageof 29